Literature DB >> 1149480

Xipamid, a potent new diuretic.

K H Piyasena, C W Havard, J C Weber.   

Abstract

The effects of xipamid and frusemide were comapred in 9 oedematous patients. Xipamid was found to be equipotent with frusemide in doses of 40 mg. and 80 mg., with respect to its effect on sodium and water excretion. The time course of action of xipamid was observed to be more prolonged than that of frusemide. It is concluded that xipamid is a potent and safe diuretic.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1149480     DOI： 10.1185/03007997509113658

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


  8 in total

1.  Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics.

Authors:  Min Ju; Toby S Scott-Ward; Jia Liu; Pissared Khuituan; Hongyu Li; Zhiwei Cai; Stephen M Husbands; David N Sheppard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Once daily treatment of mild to moderate hypertension with xipamid: a controlled study.

Authors:  J C Weber; H Bird; J Cosh; P S Davies; A S Dixon; J Lister; H V Petts; B N Prichard; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Hypokalaemia and xipamide.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27

4.  Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.

Authors:  G A MacGregor; R A Banks; N D Markandu; J Roulston
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 5.  Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B N Prichard; R N Brogden
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

6.  Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  A study of the antihypertensive action of xipamide using ambulatory intra-arterial monitoring.

Authors:  E B Raftery; D I Melville; B A Gould; S Mann; J R Whittington
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

8.  Nadolol in combination with indapamide and xipamide in resistant hypertensives.

Authors:  S Dean; M J Kendall; S Potter; M H Thompson; D A Jackson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.